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epithelial cell changes  tubular macrophages  interstitial in-Proteinuria and tubulointerstitial lesions in lupus nephritis.
flammation  interstitial fibrosis, corresponding to current ex-Background. Response of the renal tubules to proteinuria
perimental models, but not previously demonstrated in humans.is implicated in progression of renal disease. Experimentally,
proteinuria causes increased tubular synthesis of macrophagic
and other chemokines, with increased tubular cellular prolifer-
ation and apoptosis, leading to interstitial inflammation and
It has become apparent in recent years that the re-fibrosis. Clinically, diminution of proteinuria leads to the slow-
sponse of the renal tubules to proteinuria plays a centraling of progression, but whether this leads to reduction in tubu-
lar lesions has not been directly demonstrated in humans. role in the progression of renal disease [1–4]. Proteinuria
Methods. Initial (Bx1) and systematic six-month biopsies (Bx2) causes a host of different chemokines, particularly mac-
from 71 patients with lupus nephritis were studied, with a subset rophage chemoattractants [5, 6] and other proteins,of 34 biopsies also stained for proliferating cell nuclear antigen
including major histocompatibility complex (MHC) anti-(PCNA), the macrophage marker PGM1, and cytokeratins
(AE1/AE3), and morphometric cell and tubular profile counts gens [3, 4] and vasoactive substances, such as endothe-
performed. lin-1 [7] to be up-regulated in renal tubular cells, particu-
Results. Positive correlations were found between increasing larly proximal tubules. These proteins, often elaborated
levels of proteinuria and the following light microscopic param-
on the basolateral aspect of the tubule cells, can then beeters: tubular epithelial pyknosis, tubular epithelial nuclear
released into the interstitium where they enchain the“activation,” tubular lumenal macrophages, interstitial inflam-
mation and fibrosis, but not with tubulointerstitial immunofluo- appearance of T cells and macrophages, with up-regula-
rescence. Significant positive correlations also were found with tion of transforming growth factor- (TGF-), platelet-
the following immunohistochemical parameters: PCNA in epi- derived growth factor (PDGF), and other chemokinesthelial cells (r  0.74) and tubular luminal cells (r  0.47);
[3, 4, 8]. These lead in turn to fibroblast proliferation,tubular lumenal macrophages (r  0.63) and tubular epithelial
myofibroblastic transformation and ensuing interstitialcells with acquired PGM1 staining (r  0.36); and pyknotic
tubular epithelial cells (r  0.47). All showed strong correla- fibrosis [3, 4, 8]. It is also increasingly apparent that
tions with serum creatinine (SCr) as well. All were reduced complement plays a role, even in non-immune mediated
at Bx2, generally in parallel to the reduction in proteinuria.
injury [9, 10]. Experimentally, these proteinuric condi-Tubulointerstitial immune deposits appear to play only a minor
tions also are associated with tubular cell proliferationrole in the development of tubular epithelial lesions and the
progression of renal disease in lupus. They show only limited [9, 11–14] and apoptosis/pyknosis [13, 14]. Apoptosis is
correlation with SCr and no correlation with proteinuria. By usually more frequent than proliferation, leading some
multiple regression, they are not associated with tubular epithe- to suggest that this imbalance is one of the mechanismslial lesions, interstitial inflammation or interstitial fibrosis at
of tubular atrophy [13].either biopsy, whereas tubular epithelial lesions are strongly
However, a number of questions remain to be an-associated with interstitial inflammation at Bx1 and with inter-
stitial fibrosis at Bx2. Cytokeratin correlated strongly with SCr swered. Relatively limited information exists as to whether
(r  0.53, P  0.002) but not with proteinuria (r  0.27, NS), the up-regulated proteins and cytokines return toward
and was the sole immunohistochemical parameter to increase
normal with diminution of proteinuria. Most animal mod-at Bx2. It appears to be a sensitive marker for tubular atrophy.
els of proteinuria, such as 5/6 nephrectomy or the variousConclusions. In this study both proteinuria and SCr showed
a hierarchy of correlations with morphologic variables: Tubular glomerulonephritic models, lead ineluctably to renal fail-
ure. These models demonstrate that antiproteinuric
treatment leads to lesser lesions compared to untreatedKey words: renal tubules, systemic lupus, erythematosus (SLE), macro-
phages. animals [15]. However, only puromycin aminonucleoside
nephrosis offers the possibility to see the effects of reduc-Received for publication November 17, 2000
tion of proteinuria [12, 15]. During the initial proteinuricand in revised form June 20, 2001
Accepted for publication June 20, 2001 phase, there is a burst of tubular proliferation [12, 15],
accompanied by up-regulation of osteopontin [15], both 2001 by the International Society of Nephrology
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of which return to normal levels by 28 to 42 days with biopsies were carried out primarily for clinical indica-
tions and are reported elsewhere [24].disappearance of proteinuria. In humans, there have
been relatively few studies correlating morphologic alter-
Technical methods and record reviewations with level of proteinuria. They show a generally
Specifics of technical methods are given in a priorgood correlation with proteinuria [16–20], but there are
communication [21]. Briefly, biopsies were prepared andno sequential biopsy studies to show whether diminution
stained according to standard methods for light and IFof proteinuria is attended by regression of tubular prolif-
microscopy. Electron microscopy is not included in thiserative, pyknotic and other lesions.
study. For light microscopic study there were 67 usableWe studied a series of 71 patients with lupus nephritis
biopsies at Bx1 and 71 biopsies at Bx2. Photographs ofwith initial biopsies and systematic repeat biopsies after
positive IF were available in 122 (85.9%) of the 142 firstsix months of treatment, at a time when the great major-
and second biopsies. The remaining 20 biopsies had noity had marked diminution or total disappearance of their
photographs and/or contained only medulla. This mate-proteinuria. We had previously found that tubular lesions
rial was graded randomly by one author (GSH), blindoffered the best correlations with the current serum cre-
to the clinical data. A variety of clinical parameters wereatinine (SCr) value of any morphologic variable, as well
evaluated at the time of each biopsy of which the mostas good correlations with outcome [21, 22], this latter
important for this study were serum creatinine (SCr,finding confirming numerous other studies [1]. The pres-
mol/L), proteinuria (g/24 hours), and hematuria (rbcs/ent study examined in greater depth, not simply the
mL). Clinical data were available for all patients for theindividual lesions, but the interrelationships between
initial two biopsies, but for six patients the follow-upproteinuria, SCr, tubular epithelial lesions, tubulointersti-
data as to outcome were incomplete.tial immunofluorescence (IF), interstitial inflammation,
The primary outcome parameter measured was dou-and interstitial fibrosis to see what light these interrela-
bling of the initial serum creatinine (CRX2) for threetionships might shed on the pathogenesis of progressive
months or more. Also evaluated were end-stage renalrenal disease. A subset of 34 biopsies, representative of
disease (ESRD), requiring dialysis and/or transplant,the overall series in terms of SCr and level of proteinuria, and final renal function (RFlast), defined as the last SCr,also was studied to validate with immunohistochemical
with an arbitrary value of 500 mol/L assigned to alltechniques several of the morphologic parameters devel-
patients with ESRD, on dialysis or transplanted.oped on the basis of routine stains of archival material.
Morphologic variables
The schema for evaluation of morphologic variablesMETHODS
has been reported in detail elsewhere [21]. Lesions werePatient population
graded semiquantitatively on a scale of 0 to 3, de-
Renal biopsies and clinical data from 71 patients from pending on the proportion of the tubular profiles or
four Paris hospitals (Bichat, St. Louis, Broussais, and interstitium involved: 0  absence of lesions; 0.5 
Henri Mondor) from the period 1986 to 1994 were evalu- lesions present, but minimal (5 to 10% of the tubules
ated. Demographic characteristics have previously been or interstitium according to the variable); 1  lesions
described [21, 22]. Cases were categorized according to involving up to 25%; 2  lesions involving 25 to 50%;
1982 WHO criteria [23]. Initial diagnoses were diffuse 3  lesions involving 50% of the tubules or intersti-
proliferative lupus nephritis (WHO Class IV), 55 patients; tium. As best possible, judgments were based on compar-
focal proliferative lupus nephritis (WHO Class III), 9 ing the cells and nuclei in the affected tubule with those
patients; and mixed membranous and focal or diffuse in normal profiles of the same nephron segment, that is,
proliferative lupus nephritis (WHO Class Vc and Vd), proximal, distal, etc. elsewhere in the section. The lesions
7 patients. All patients had an initial renal biopsy (Bx1) most germaine to this study are defined as follows.
as part of a treatment protocol approved by the appro- Tubular nuclear pyknosis (tubpyk). Pyknosis in tubu-
priate committees at the four hospitals. The six-month in- lar epithelium was defined as shrinkage of nuclear pro-
duction treatment consisted of monthly intravenous cyclo- files with condensation of the nuclear chromatin to a
phosphamide combined with prednisone (0.9  0.4 mg/ solid black, often hyaline appearance, with ultimate frag-
kg · body weight/day for one month tapered to 0.4  mentation.
0.1 mg/kg · body weight/day at six months) in 58 patients, Tubular nuclear “activation” (tubact). Nuclear “acti-
and corticosteroids alone in 13 patients (1.4  0.3 mg/kg vation” was defined cytologically by generalized nuclear
body weight/day tapered to 0.5  0.16 mg/kg · body enlargement with variation in nuclear size and shape,
weight/day at 6 months). Initial treatment was followed prominent nucleoli, and irregularities of nuclear chroma-
at six months by re-evaluation and control renal biopsy tin with zones of clearing and clumping on the nuclear
membrane.(Bx2) to evaluate the effects of therapy. Subsequent
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Macrophages in tubular lumens (macrlum). Macro- counted, with the exception of several biopsies where
limited material prevented this. The minimum numberphages in tubular lumina were identified primarily by
their biconcave-to-ovoid nuclei and crisp cell mem- of grids counted was 72. The following morphologic com-
partments were evaluated: (a) for PGM1: (1) tubularbranes, usually with evident cytoplasmic vacuoles and/or
inclusions but occasionally without. Usually these cells lumenal macrophages; (2) cells staining positively for
PGM1 within the tubular epithelium; (3) interstitial mac-were found free in the tubular lumina, but occasionally
they could be found attached to the tubular epithelial rophages; (b) for PCNA: (1) tubular epithelial cells; (2)
PCNA cells in tubular lumens; (c) for pyknosis oncells. Every effort was made to distinguish them from
sloughed epithelial cells, which generally had pyknotic routine stains: (1) tubular epithelial cells; (2) pyknotic
cells in tubular lumens; (d) for AE1/AE3, number ofnuclei and more eosinophilic cytoplasm with ragged cell
borders. tubular profiles containing AE1/AE3 cells per grid.
Tubules with a single AE1/AE3 cell were counted asAlso evaluated and quantitated in similar fashion [21]
were tubular necrosis (tubnec), tubular cell flattening positive.
(tubflat), and epithelial cells in tubular lumina (eplum).
Statistical analysesTubulointerstitial deposits on IF (tubulif). To evaluate
tubulointerstitial deposits on IF, antisera to the following In comparing continuous clinical variables (such as
SCr) with semiquantitative variables, such as tubular flat-were employed in all cases: IgG, IgA, IgM, C3, C1q, and
fibrinogen. Each was graded 0 to 4 according to the tening graded 0 to 3, with continuous variables, Pear-
son product-moment correlation coefficients were calcu-percentage of tubulointerstitium involved, for a maxi-
mum possible score of 24 for the 6 antisera. (Although lated. For comparisons of semiquantitative variables with
one another and for categorical variables (for example,tubular basement membranes often could be distin-
guished from interstitial staining, this was far from uni- the presence or absence of ESRD), the Spearman rank
order correlation test was used. Since these correlationsversal, so the tubulointerstitium was considered as a unit.)
are very extensively cited, to maintain continuity in the
Immunohistochemistry text they will usually appear simply in parentheses, with
asterisks used to indicate the level of probability: *P Immunostaining for the macrophage marker PGM1
(Dakopatts, Trappes, France), proliferating cell nuclear 0.05; **P 0.01; ***P 0.001; ****P 0.0001. Stepwise
multiple regression was used in defining the significanceantigen (PCNA; Dakopatts) and cytokeratins (AE1/
AE3; Dakopatts) was performed on a subset of biopsies of associations between morphologic variables in se-
lected situations.from the overall series, selected to be representative of
the overall series in terms of SCr and proteinuria at Bx1.
Initially specimens from Bx1 and Bx2 were stained in 18
RESULTS
patients. However, 2 specimens at Bx1 were technically
Immunohistochemical studiesunsatisfactory, leaving a total of 34 biopsies, 16 from
Bx1 and 18 from Bx2. They were prepared as follows: Immunohistochemical studies were carried out to vali-
date the morphologic variables, tubular lumenal macro-Freshly cut paraffin slides were digested with pronase
for PGM1 and AE1/AE3, or microwaved for five minutes phages using PGM1, tubular nuclear “activation” using
PCNA, and nuclear pyknosis by quantitative counts ofin EDTA pH 8 solution, followed by blocking with goat
serum diluted 1/20 for 20 minutes. They were then incu- pyknotic cells performed on the same slides at the same
time as counts of PCNA cells. The distribution of cy-bated 30 minutes with PGM1 diluted 1/200, PCNA 1/100,
or AE1/AE3 1/100, washed with TRIS buffer, pH 7.4, tokeratin was evaluated using AE1/AE3. Correlations
between the various parameters and also with SCr andfollowed by 30 minutes’ incubation with horse anti-mouse
biotinylated antibody (Vector, Burlingame, CA, USA), proteinuria are presented in Table 1.
Macrophages. These have been reported in detail indiluted 1/200 to detect the PGM1 or other marker, washed,
then incubated with a preformed avidin-biotinylated al- a previous communication [22]. Briefly, there was a good
correlation between tubular macrophages identified onkaline phosphatase complex (Vectastain ABC Reagent;
Vector). Development with Vector Red AEC substrate routine stains and those tagged by PGM1 (r  0.54**),
and we noted frequent staining of tubular epithelial cellsand counterstaining with hematoxylin completed the
process. by PGM1, suggesting possible transdifferentiation, al-
though this was not confirmed by double labeling in
Cell and tubular profile counts the present study. Using both routine stain and PGM1,
tubular macrophages at Bx2 also had an excellent corre-Slides were examined using an ocular grid with an
overall area of approximately 10,000 2 at 40 magnifi- lation with later development of renal insufficiency (r 
0.56*). Equally importantly from the standpoint of patho-cation. Only cortical parenchyma was evaluated. For
each biopsy at least 100 grids of tubulointerstitium were genesis, they had an extremely high correlation with both
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Table 1. Correlation betwween various prophologic, immunohistochemical, and clinical parameters
TubLumMacr TubCytMacr Pyknosis
Proteinuria SCr (PGM1) (PGM1) PCNA (count) Cytokeratin
PCNA-positivity 0.74a 0.55a 0.89a 0.47a — 0.64a 0.57a
Tubular lumenal macrophages (PGM1) 0.63a 0.54a — 0.74a 0.89a 0.81a 0.34
Pyknosis (count) 0.47a 0.50a 0.81a 0.54a 0.64a — 0.53a
Tubular cytoplasmic PGMI positivity 0.36a 0.39a 0.74a — 0.47a 0.54a 0.15
Cytokeratin 0.27 0.53a 0.34 0.15 0.57a 0.53a —
This subset of 34 biopsies with immunohistochemical studies used Pearson product-moment correlations for the analysis.
a Significant at P  0.05
PCNA positivity (r 0.98***) and tubular pyknosis (r mal kidneys is limited to the distal nephron, from the
distal tubules onwards. However, we had noted in other0.91**), but only lesser, nonsignificant correlations with
cytokeratin (r  0.65, P  0.15). studies that cytokeratin often stains atrophic tubules, so
it was studied here. Cytokeratin staining appeared firstProliferating cell nuclear antigen. It rapidly became
apparent that only a minority of cells with characteristics in individual tubular cells, being distributed particularly
near the cell membrane (Fig. 2). At first only one or twoof nuclear “activation” (nuclear enlargement, prominent
nucleoli, increased chromatin with clumping on the nu- cells per tubular profile stain were found in tubules that
otherwise showed no evidence of atrophy, that is, with noclear membrane, etc.) was positive for PCNA (Fig. 1),
in accordance with general cytopathologic experience. thickening of the tubular basement membrane, and with
intact brush borders in other cells. Gradually, the stain-Nonetheless, there was a very good correlation between
PCNA and tubact (r  0.51**). They, however, differed ing became more extensive both in intensity per cell and
in percentage of cells involved, as the standard stigmatain their degree of correlation with the level of protein-
uria, that of PCNA being very strong (r  0.71***), of tubular atrophy appeared. However, even fairly late,
individual cells negative for cytokeratin could be seen inwhereas that with tubact was weaker (r  0.27**).
Proliferating cell nuclear antigen positive cells in the atrophic tubules, and very rarely, small, shrunken tubules
with thickened basement membranes typical of advancedtubular lumens were very much rarer than PCNA tubu-
lar epithelial cells (35.0  30.1 vs. 0.8  1.4 cells/100 tubular atrophy were negative for cytokeratin. However,
the vast majority of obviously atrophic tubules stainedgrids), and were present in only 13 of 30 biopsies. How-
ever, their presence connoted worse disease, with higher uniformly and intensely for cytokeratin. In addition, some
cases, usually those with severe disease, showed scattered,SCr levels (165  53 vs. 100  30 mol/L, P  0.0004)
and greater proteinuria (6.4  4.7 vs. 2.4  1.9 g/24 h, isolated AE1/AE3 cells in the interstitium (Fig. 2).
Cytokeratin showed an excellent correlation with semi-P  0.005). As might be anticipated, PCNA positivity
in tubular cells was significantly higher in the group with quantitative estimates of tubular atrophy of r  0.56***
(despite the fact that many tubules with limited/earlyPCNA lumenal cells (48.9  37.7 vs. 22.3  15.8 cells/
100 grids, P  0.02). cytokeratin positivity showed no atrophy by routine mi-
croscopy). As with the other tubular markers, cytokera-Pyknosis. It would have been preferable to study py-
knosis/apoptosis by the TUNEL technique [25]. Unfor- tin here showed a strong correlation with SCr (r 0.53**).
However, unlike the others, it showed no significant cor-tunately, it could not be made to give reliable results for
cell counts on these biopsies because they were fixed in relation with the level of proteinuria (r 0.27, P 0.13).
Cytokeratin differs in two other important respects fromBouin’s fixative containing picric acid. We therefore relied
on cell counts of pyknotic cells, performed on the same the other markers studied: (1) It shows no correlation with
macrophage markers, either tubular lumenal or tubularslides and at the same time as the counts of PCNA cells.
There was a very good correlation between counts of epithelial (Table 1). (2) It increases from Bx1 to Bx2,
whereas all of the other cellular markers decline (Fig. 3).tubular epithelial cell pyknosis and tubpyk, estimated
semiquantitatively on routine stains (r  0.53**). Py- Correlations between markers and serum creatinine
and proteinuria. All of the immunohistochemical mark-knotic cells were more frequent in the tubular epithelium
(52.6 24.4 cells/100 grids) and in tubular lumina (23.3 ers showed strong correlations with SCr, and all save
cytokeratin showed strong correlations with proteinuria13.4 cells/100 grids) than PCNA cells in these locations.
However, unlike PCNA tubular luminal cells, pyknotic (Table 1). In addition, subdivision by level of proteinuria
showed that all of the markers increased progressivelycells in the lumina were present to some extent in all
cases and correlated only with increasing proteinuria (r with increasing proteinuria (Fig. 4), save cytokeratin, and
that these changes were greater than the associated mod-0.35*), not worsening renal function.
Cytokeratin. Cortical staining for cytokeratin in nor- est increase of SCr. It was further noted that, corresponding
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Fig. 2. Staining for cytokeratin (AE1/AE3). A dilated distal tubule (cen-
ter) as well as several profiles of atrophic tubules stain positively, as doesFig. 1. Staining for proliferating cell nuclear antigen (PCNA). In addi-
the parietal epithelium lining the Bowman’s capsule, a common findingtion to several brown-staining PCNA nuclei, the majority of tubular
in glomerular inflammatory lesions. Some tubules show individual tubu-nuclei show changes of nuclear “activation” with nuclear enlargement
lar cell staining for PCNA in the absence of other signs of atrophy,and irregularity with prominent nucleoli. For comparison, arrows mark
although the tubular lumina are somewhat dilated. An interstitial cella group of reasonably normal proximal and distal tubular nuclei at
(arrow) is also cytokeratin positive. Hematoxylin counterstain, 300.the top. In addition, several pyknotic tubular nuclei are indicated by
arrowheads. Hematoxylin counterstain, magnification 350.
Fig. 5. Quadratic surfaces formed by interaction of correlations between PCNA-positivity and nuclear pyknosis (x and y axes) versus proteinuria
(A) and tubulointerstitial immunofluorescence (B; IF; z axis). In the plot against proteinuria, the quadratic surface forms a clear cut, sharp central
peak, highest at the highest values for all three variables, with most points in the center and at or near the quadratic surface. By contrast, on the
quadratic surface plotted for tubulointerstitial IF (B), there is no central peak and many points are well away from the quadratic surface.
to the decrease in proteinuria between Bx1 and Bx2, there SCr, proteinuria, and the outcome variables, CRX2 and
RFlast were compared with tubulointerstitial and chronic-was a parallel decrease, generally statistically significant,
in all of the parameters save for cytokeratin (Fig. 3). ity variables in the series as a whole (Table 2). First, a
general hierarchy of correlations with these variables
Overall series could be established, with tubular epithelial variables
Correlations with serum creatinine and proteinuria and showing the strongest correlations, slightly weaker corre-
lations for tubular luminal macrophages and interstitialoutcome variables. An interesting pattern emerged when
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Fig. 3. Changes in mean values for immunohistochemical variables from
Bx1 to Bx2, standardized to 1 for initial values. Values fall generally
Fig. 4. Staining for various immunohistochemical markers compared toin parallel with proteinuria (bold line), whereas serum creatinine (SCr)
the degree of proteinuria in a subset of 34 biopsies. Values are standard-declines by lesser amounts. Cytokeratin is the sole immunohistochemi-
ized such that the mean for each parameter equals 1. The variouscal value to rise between biopsies. Symbols are: () cytokeratin; ()
markers increase with the increasing proteinuria, as does SCr, as indicatedSCr; () pyknotic tubular cells; () interstitial macrophages; (*) pyknotic
with the bold line. However, the SCr is above normal limits only forcells in tubular lumina; () proliferating cell nuclear antigen (PCNA)
Prot 4 g/24 h. Symbols are: () tubular luminal macrophages; ()tubular cells; () proteinuria; () tubular epithelial PGM-1 positivity;
PCNA cells in tubular lumina; () PCNA tubular cells; () intersti-() tubular luminal macrophages; () PCNA cells in tubular lumina.
tial macrophages; () SCr; () pyknotic tubular cells; () cytokeratin;
() tubular epithelial PGM1 positivity.
inflammation, and yet weaker, often nonsignificant cor-
relations with tubular atrophy and interstitial fibrosis. significant tubular epithelial lesions in the absence of
Tubulointerstitial IF showed the poorest overall correla- any tubulointerstitial IF staining whatever. Similarly, an
tions with the above variables, correlating relatively impressive number of patients (11 at Bx1 and 18 at Bx2)
poorly with SCr and not at all with proteinuria. Second, showed interstitial inflammation in the absence of any
SCr showed an even stronger correlation with all these tubulointerstitial deposits by IF. Tubular epithelial le-variables than did proteinuria. Multiple regression con-
sions seemed linked to interstitial inflammation ratherfirmed that both tubular epithelial variables and intersti-
than to tubulif, in that those with inflammation but notial inflammation were significantly related to SCr at Bx2 deposits showed means for tubular epithelial lesions(P  0.00009 and 0.0025, respectively), but that tubulo-
close to the group as a whole (3.8  2.4 vs. 4.2  2.5,interstitial immune deposits were not (P  0.57).
NS), whereas those with deposits but no inflammationRelationship between tubular epithelial variables, tubulo-
(7 patients at each biopsy) had lower-than-average tubu-interstitial IF, and interstitial inflammation and fibrosis.
lar epithelial lesions (2.4  1.5, P  0.03).Tubular epithelial lesions and tubulif showed no signifi-
The relative differences in the correlations of the tubu-cant association with one another at either biopsy, either
lar epithelial variables with proteinuria versus their cor-in terms of Pearson correlation coefficients (Table 2)
relation with tubulif are perhaps best demonstrated visu-or by stepwise multiple regression (Table 3). Further,
ally. Figure 5 represents the quadratic surfaces formedstepwise multiple regression revealed that tubular epi-
by the interacting correlations between PCNA-positivitythelial lesions were strongly associated with interstitial
and nuclear pyknosis in the x and y axes with proteinuriainflammation at Bx1 (prior to treatment for most pa-
(Fig. 5A) or tubulif (Fig. 5B) in the z axis. In the plottients), and with interstitial fibrosis after treatment at
against proteinuria, the quadratic surface forms a clear-Bx2, but that tubulif was not significantly associated with
cut, sharp central peak, highest at the highest values forany of them (Table 3).
all three variables, with most points in the center atConsonant with these correlations, a number of biop-
sies at both Bx1 (8 patients) and Bx2 (13 patients) showed or near the quadratic surface. By contrast, for tubulif
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Table 2. Correlations between tubulointerstitial, clinical and outcome parameters
Tubular Tubular Interstitial Interstitial Tubular Tubint.
epithelial macrophages inflammation fibrosis atrophy IF
Clinical and outcome parameters
Biopsy 1
Proteinuriab 0.27a 0.23 0.10 0.19 0.17 0.05
SCrb 0.35a 0.51a 0.35a 0.27a 0.28a 0.31a
CRX2c 0.23a 0.24 0.19 0.14 0.15 0.11
RFlastb 0.42a 0.33a 0.27a 0.21 0.19 0.12
Biopsy 2
Proteinuriab 0.33a 	0.01 0.25a 0.26a 0.24 0.08
SCrb 0.49a 0.43a 0.52a 0.47a 0.47a 0.25
CRX2c 0.23a 0.39a 0.15 0.15 0.17 0.36a
RFlastb 0.40a 0.43a 0.20 0.25 0.25 0.20
Biopsy 1  2
Proteinuriab 0.34a 0.26a 0.24a 0.08 0.06 0.07
SCrb 0.48a 0.51a 0.45a 0.32a 0.29a 0.30a
CRX2c 0.28a 0.24a 0.16 0.14 0.16 0.21a
RFlastb 0.42a 0.36a 0.23a 0.23a 0.21a 0.15
Morphologic parameters
Biopsy 1
Tubep — 0.59a 0.55a 0.41a 0.44a 0.25
Tubulif 0.25 0.27a 0.43a 0.43a 0.36 —
Biopsy 2
Tubep — 0.39a 0.33a 0.57a 0.45a 0.16
Tubulif 0.16 0.27a 0.31a 0.20 0.17 —
Biopsy 1  2
Tubep — 0.53a 0.46a 0.46a 0.45a 0.27a
Tubulif 0.27a 0.34a 0.46a 0.30a 0.31 —
Abbreviations are: Tubint. IF, tubulointerstitial deposits in immunofluorescence; SCr, serum creatinine; CRX2, doubling of the initial serum creatinine; RFlast, final
renal function; Tubep, tubular epithelium (tubep tubpyk tubact tubnec tubflat eplum); tubpyk, tubular nuclear pyknosis; tubact, tubular nuclear activation;
tubnec, tubular necrosis; tubflat, tubular cell flattening; eplum, epithelial cells in tubular lumens.
a Value significant at P  0.05 (boldface)
b Pearson product-moment correlation
c Spearman rank correlation
Table 3. Association between tubular epithelial lesions, interstitial inflammation, interstitial fibrosis and
tubulointerstitial immunofluorescence by stepwise multiple regression
Tubular epithelial lesions Interstitial inflammation Interstitial fibrosis Tubulointerstitial IF
Variable  P Variable  P Variable  P Variable  P
Biopsy 1
Intinfl1 0.4849 0.00003 TubEp1 0.4140 0.001 Intinfl1 0.5557 0.00001 Intfib1 0.2701 0.10
Macrlum1 0.3899 0.0005 Intfib 0.3465 0.002 Tubulif1 0.1955 0.10 Intinfl1 0.2554 0.12
Tubulif1 0.1489 0.13
Macrlum1 0.1165 0.32
Biopsy 2
Intfib2 0.6070 0.000005 Intfib2 0.7086 0.000008 Intinfl2 0.5433 0.000005 Intinfl2 0.2354 0.14
Macrlum2 0.1821 0.12 Macrlum2 0.2123 0.068 TubEp2 0.4644 0.00004 Macrlum2 0.1594 0.31
Tubulif2 0.1379 0.21 Macrlum2 	0.1028 0.29
TubEp2 	0.1417 0.32
Abbreviations are in Table 1 and: Intfib, interstitial fibrosis; Intinfl, interstitial inflammation; Tubulif, tubulointerstitial immunofluorescence. TubEp  tubpyk 
tubact  tubnec  tubflat  eplum (see Morphologic variables). Biopsy 1 comprised 55 untreated patients, and 12 previously treated patients and biopsy 2 comprised
71 treated patients.
(Fig. 5B), there is no such central peak and many points cells identified by TUNEL [26–28]. In our material tubu-
lar nuclear pyknosis is frequent and shows significantare well away from the quadratic surface.
positive correlations with SCr and proteinuria (Table 1,
Figs. 4 and 6), indicating that it increases with disease
DISCUSSION
activity. This increase in pyknosis suggests but does not
Tubular nuclear activation and pyknosis prove an increase in tubular apoptosis in SLE.
Tubular nuclear “activation.” There is a marked in-Pyknosis. Studies comparing light microscopic identi-
fication of pyknosis with TUNEL staining show an ex- crease in cellular proliferation in the tubulointerstitium
in systemic lupus erythematosus (SLE) nephritis, as indi-ceedingly high correlation between the two (r  0.90),
but light microscopy recognizes only 45 to 70% of the cated by a marker for proliferation, PCNA [29], and
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proteinuria to renal scarring. It is only poorly correlated
with proteinuria, in comparison with PCNA and pyknosis,
but does show good correlations with tubular atrophy
and fibrosis. It seems, in fact, to be an excellent marker
for tubular atrophy. Almost all overtly atrophic tubular
profiles, with narrowed lumens and thickened TBMs, in
all specimens examined were AE1/AE3 positive, the ex-
ceptions constituting certainly no more than 1% of total
atrophic tubules. Overall, the amount of AE1/AE3 stain-
ing mounted between Bx1 and Bx2, in contrast to decline
of all other immunohistochemical variables. Our impres-
sion from review of the slides is that minor degrees of
cytokeratin staining are reversible, but we have too few
cases with declines to demonstrate this conclusively.
Cytokeratin staining of renal tubules has not received
a great deal of attention in the literature, most studies
using cytokeratin markers as markers of the level of
nephron in studies of renal cystic disease or renal tumors.
However, Moll et al performed a detailed study of inter-
mediate filaments in fetal, adult, and diseased kidneys
in which they described the neo-expression of cytokeratins
7 and 19 in damaged and atrophic tubules at all levels
Fig. 6. Comparison of various tubulointerstitial lesions in the overall of the nephron, as well as vimentin in all save distal tubulesseries, plotted against increasing proteinuria. Serum creatinine (SCr)
[31]. They interpreted these findings as an expression ofmounts with increasing tubular lesions, but is only above normal limits
for Prot 4 g/24 h. Symbols are: () tubular lumenal macrophages; dedifferentiation. Coexpression of vimentin and cytoker-
() interstitial inflammation; () tubular nuclear “activation”; () SCr; atin also has been described in damaged tubules in Bal-() tubular pyknosis; () interstitial fibrosis.
kan nephritis [32], as well as in experimental renal ischemia
[33]. Relative ischemia is a common thread in a number
of types of nephropathy. Diminution and disappearance
similar increases have been seen in other renal conditions of the peritubular capillary network in chronic renal dis-
using another proliferation marker, Ki-67 [30]. Our study ease is an old observation [34], recently resurrected [14,
confirms these observations. However, this study equally 35, 36]. However, in addition to simple ischemia in the
made it apparent that PCNA cells constituted only a relative dedifferentiation of these tubular epithelial cells,
portion of the cells with features of nuclear “activation”
it seems likely that nonischemic inflammatory processes
that the cytologist associates with increased metabolic
will be found to be involved as well.
activity and protein synthesis.
This study also demonstrates that the levels of both Tubular epithelial lesions and proteinuria and
tubact and PCNA tubular cells and of pyknotic cells serum creatinine
are correlated with the level of proteinuria, and that they
The present study confirms the relationships betweendiminish with diminution of proteinuria. Although changes
proteinuria and tubular epithelial lesions, with their en-in PCNA-positivity have been demonstrated previously
trained interstitial inflammation and fibrosis. As seen inin puromycin aminonucleoside nephrosis (PAN) in the
Tables 1 and 2, tubular epithelial lesions have a signifi-rat [15], this is the first demonstration that this occurs
cant correlation with proteinuria at both time periods,in humans, and equally the first demonstration of changes
as well as with outcome. Further, these elements showin numbers of pyknotic tubular cells with level of protein-
a definite increase with increasing levels of proteinuria,uria. Also, as has been described in other situations [13],
and at the lower levels of proteinuria this increase occurshere the pyknotic tubular epithelial cells were more fre-
in patients whose SCr values are still normal (Figs. 4 and 6).quent than PCNA cells. It seems reasonable to assume,
However, tubular epithelial lesions, interstitial inflam-as others have proposed [13], that the altered balance
mation and fibrosis are even more strongly correlatedbetween pyknosis and proliferation contributes to the
with SCr than with proteinuria (Table 2). This is likelyadvance of tubular atrophy.
related to tubular dysfunction, either as a result of the
Cytokeratin noxious effects of proteinuria or by independent mecha-
nisms. Tubular dysfunction occurs in many renal diseases,Tubular AE1/AE3 staining appears to represent a
more advanced stage in the progression of events from including SLE [37], as manifest by increased enzymuria
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during the active phases [38–40], and experimentally cor- the presence of tubulointerstitial deposits and interstitial
inflammation [46]. In our study, there was a significantrelates with the degree of tubular damage [38, 39].
The strong correlation between tubular epithelial le- correlation between the two, but there were numerous
exceptions in both directions as indicated above. Twosions and SCr is of particular interest. Over the years it
has been shown that in a variety of glomerular diseases, other studies examining immune complexes and intersti-
tial inflammation in lupus came to the conclusion thatincluding SLE [41], impairment of renal function corre-
lates more closely with the extent of interstitial fibrosis interstitial deposition of immune complexes may play a
pathogenic role in interstitial inflammatory processes,than with glomerular lesions [35, 42, 43]. In addition,
there is an inverse correlation between SCr and the num- but considered that its prognostic significance is minor
[20, 47]. A recent report, however, describes eight cases,bers of postglomerular interstitial capillaries [35], and in
some diseases a direct correlation between SCr and the most associated with lymphoproliferative disorders, in
which massive tubulointerstitial deposits were associateddegree of interstitial inflammation [44].
However, our study suggests that the correlations of with tubulointerstitial nephritis in non-lupus patients
[48]. Thus, a potential role for tubulointerstitial depositsinterstitial inflammation and interstitial fibrosis in these
situations with SCr are in part secondary to their associa- in lupus cannot be eliminated, but rather simply be di-
minished in importance.tion with tubular epithelial lesions. As Table 2 reveals,
interstitial fibrosis is more weakly associated with SCr at
Diminution of interstitial fibrosisthe time of biopsy and with outcome variables than are
tubular epithelial lesions, tubular lumenal macrophages Our most recent study found that interstitial fibrosis
may actually diminish in response to therapy, (presum-or interstitial inflammation. Multiple regression [21] con-
firms these impressions, indicating that neither glomerulo- ably because of an altered balance between the enzymes
responsible for degradation and their inhibitors, whichsclerosis nor interstitial fibrosis is significantly associated
with SCr at either biopsy, whereas tubular nuclear “activa- would lead to its accumulation), and such cases are at-
tended by an excellent prognosis [24]. The cases in whichtion,” tubular necrosis, tubular macrophages, and inter-
stitial inflammation are significantly associated. The only fibrosis diminishes show striking diminution of protein-
uria and its consequent tubular lesions, whereas thoseprevious study to deal directly with tubular measure-
ments found that in a variety of glomerular diseases there cases where interstitial fibrosis increases are marked by
continued high level proteinuria and tubular lesions.was a strong association between creatinine clearance
and proximal and distal tubule area percentages [45].
Conclusions
Relative roles of tubular epithelial lesions and The above data allow us to construct a rough hierarchy
tubulointerstitial immune deposits in the relationship between proteinuria and the various
morphologic lesions (Tables 2 and 3). Tubular epithelialThis study suggests that tubulointerstitial immune de-
posits play only a minor role in the development of lesions, particularly PCNA-positivity and pyknosis, are
the most closely related; inflammatory lesions, both in-tubular epithelial lesions, and that proteinuria is more
important in the origin of the latter. First, there is no tratubular and interstitial, are somewhat less closely re-
lated; and interstitial fibrosis and tubular atrophy, bothsignificant correlation between tubular epithelial lesions
and tubulif at either biopsy, nor any association between directly and as manifest by AE1/AE3 positivity, the least
closely connected. This hierarchy is in accord with thethem on multiple regression (Tables 2 and 3). Second,
tubular epithelial lesions were significantly correlated sequence of events proposed in current models of pro-
teinuria-related renal damage [2–4]. These data supportwith proteinuria (Table 2), and worsened with increasing
proteinuria (Figs. 4 and 6) whereas tubulif was not corre- the notion that interstitial fibrosis and decline in renal
function are secondary to the tubular epithelial lesions.lated with proteinuria.
This study also suggests that tubular epithelial lesions Specifically in lupus nephritis, they suggest that the tubu-
lar epithelial lesions are primarily secondary to protein-are more important than tubulointerstitial deposits in
the progression of renal disease, in that they were more uria and not to tubulointerstitial immune deposits, which
appear to play a minor role. It may be helpful to conceivestrongly associated with interstitial fibrosis, particularly
at Bx2 (Table 2). Further, stepwise multiple regression of the tubulointerstitial lesions in terms of their revers-
ibility, with nuclear activation/proliferation and pyknosisindicated that tubular epithelial lesions were strongly
associated with interstitial inflammation at Bx1 and with being completely reversible, and lesions such as intersti-
tial fibrosis (and possibly cytokeratin positivity) beinginterstitial fibrosis at Bx2, whereas tubulointerstitial de-
posits were not significantly associated with either vari- potentially partially reversible. These data thus provide
a missing link at the midpoint in the chain of evidenceable at either biopsy (Table 3).
Relatively few human biopsy data are available on extending from experimental to clinical data, implicating
proteinuria in the pathogenesis of renal failure.this subject. Park et al found no correlation between
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